Global Medical REIT Inc. (GMRE)
Global Medical REIT Inc. (GMRE) is a real estate investment trust that primarily focuses on acquiring, developing, and managing healthcare-related properties across the United States. Its portfolio includes medical office buildings, outpatient facilities, and other healthcare properties, established to serve medical practitioners, hospitals, and healthcare systems, and aimed at providing healthcare services in growing markets.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| October 15, 2025 | $0.75 | 2025-09-29 | 2025-09-29 |
| July 9, 2025 | $0.15 | 2025-06-20 | 2025-06-20 |
| April 9, 2025 | $0.21 | 2025-03-21 | 2025-03-21 |
| January 8, 2025 | $0.21 | 2024-12-20 | 2024-12-20 |
| October 8, 2024 | $0.21 | 2024-09-20 | 2024-09-20 |
Dividends Summary
- Global Medical REIT Inc. has issued 58 dividend payments over the past 11 years
- The most recent dividend was paid 7 days ago, on October 15, 2025
- The highest dividend payed out to investors during this period was $0.75 per share
- The average dividend paid during this period was $0.16 per share.
Company News
Global Medical REIT has experienced a significant 60% stock decline since December 2021, but shows signs of potential recovery with analysts turning bullish and the stock forming a support base around $30. Recent analyst upgrades and improving market conditions suggest a possible turnaround.
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -4.17% and 0.29%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Discover why now is the opportune time to be a dividend investor, the optimal yield to pursue, and why chasing higher yields may not be worthwhile. Read more here.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Tr...
